Middlemore Clinical Trials
Private Bag 93311 New Zealand,
+64 9 270 9758  http://www.middlemoretrials.nz
Current and Upcoming Research Studies
To check your eligibility, please enter some information about yourself or call us on 0800 27 27 84. Any information you enter will be confidential and protected under the Privacy Act and the Health Information Privacy Code. This is simply a quick check to see if a study may be suitable for you. If it appears you are eligible for a study, one of our recruiters will be in touch with you shortly to provide you with more details.

Study NameEligibilitySend Info
Adolescent Bariatric StudyAged between 15 years 9 months and 18 Obesity with a BMI >35 Diagnosed with either pre-diabetes or type 2 diabetes
Ankylosing Spondylitis/Axial SpondyloarthritisAge 18 years or older, have diagnosed Axial Spondyloarthritis
BRII-179-835-001 (Ph2 HBV Combo study)Age 18 – 60 years and have Chronic Hepatitis B infection
Chronic Hepatitis BAge 18 – 65 years and have Chronic Hepatitis B infection
CKD / Type 2 DiabetesAre you aged ≥18 ≤79? Have been receiving stable treatment for your diabetes and diabetic kidney disease for the past 3 months? Are you able to participate in a study for up to 26 weeks?
DeLIVERAre you aged between 22 and 70? Have you been diagnosed with Type 2 Diabetes? Are you on a consistent drug regimen of Metformin or Metformin/Vildagliptin only? Do you have a waist circumference ≥102 cm (male) and ≥88 cm (female)? Have you been diagnosed with hypertension:SBP ≥140 mmHg OR on ≤2 hypertension medications with SBP ≥130 mmHg?
IMG-7289-CTP-201Age over 18 Diagnosis of Essential Thrombocythemia Failure of standard therapy, e.g. Hydroxyurea
KER-050 Anemia in MDSAge over 18 Diagnosed with Myelodysplastic syndrome Anemia
Maneuver (CSL346_2001)Aged 25 years and older Current diagnosis of Type 2 Diabetes
Momentum (SRA-MMB-301)Age over 18, Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis, Previously treated with Ruxolitinib
PACEAged between 40 and 85 years Diagnosed with COPD Have an a COPD exacerbation requiring OCS and/or antibiotics wihtin the last 12 months A history of cardiovascular disease, including heart failure, ischaemic heart disease, tachyarrhythmias, and hypertension
Piranga [WV41073 (CHB)]Aged 18 to 65 Chronic Hepatitis B infection On stable NUC treatment (e.g Entecavir orTenofovir)
Polypill ActiveAged 18 years or older, hypertensive, no more than 3 current blood-pressure lowering medications.
ResveratrolAged over 18 years Confirmed diagnosis of bronchiectasis within 5 years Pulmonary exacerbation requiring antibiotics in the past 12 months
RSV OA TrialAged 60 or older, healthy or medically stable, and yet to recieve an annual influenza vaccine?
RSV TrialAge 18 - 49 years with an uncomplicated, singleton pregnancy with no known increased risk for complications, no history of severe adverse reaction associated with a vaccine and/or severe allergic reaction (e.g. anaphylaxis) to a previous vaccine, pre pregnancy body mass index (BMI) < 40 kg/m^2
RSV TrialBaby born after October 2020, at 35 weeks gestation or above
Select - GCA (M16-852)Age 50 years or older, have diagnosed Giant Cell Arthritis, headache/jaw pain/vision loss, shoulder and/or hip pain
Type 2 Diabetes/Chronic Kidney DiseaseAge between 18-75 Diabetic Kidney Disease Type 2 Diabetes
Ulcerative colitisAge less than 65 years, have diagnosed ulcerative colitis and experiencing increase in daily stool frequency and/or rectal bleeding, no allergy to antibiotic vancomycin, willing to undergo two colonoscopy procedures as part of the study (3 months apart)
Click [Send Info] to receive more information about the research studies selected above:

www.bio-optronics.com
Visit our website to learn how Clinical Conductor is helping this site to manage its trials.